zilebesiran   Click here for help

GtoPdb Ligand ID: 14723

Synonyms: AD-85481 | ALN-85481 | ALN-AGT01
Compound class: Nucleic acid
Comment: Zilebesiran (ALN-AGT01) is a small interfering RNA (siRNA) that is designed to target angiotensinogen (AGT) mRNA in the liver as a mechanism to treat hypertension [1-2]. The molecule is N-acetylgalactosamine (GalNAc) modified to enhance hepatic delivery via binding to liver-expressed asialoglycoprotein receptors (ASGRs). In the nucleotide sequences provided here (from the INN record) the GalNAc sugar is attached at the R1 position. The nucleotides are chemically modified (2'-O-methylnucleotides/2'-MOE and 2'-deoxy-2'-fluoronucleotide/2'-F monomers), with a mixed phosphorothioate/phosphate backbone.
References
1. Imbalzano E, Inciardi RM, Orlando L, Amati F, D'Ascenzi F, Liga R, Mattioli AV, De Fazio MG, Pastore MC, Rinaldi A et al.. (2026)
RNA-targeted therapeutics in arterial hypertension.
Eur Heart J Qual Care Clin Outcomes, 12 (3): 358-365. [PMID:41122024]
2. Lemine M, Almuzainy S, Aljubeh R, Alilo A. (2024)
Zilebesiran and Hypertension: A Systematic Review and Meta-analysis.
J Saudi Heart Assoc, 36 (4): 420-430. [PMID:39781230]